This study observed that patients with more advanced stages of ovarian cancer displayed an overexpression of Nectin-2 in cancer cells, a lower expression of Nectin-2 in peritoneal endothelium cells, and a significantly higher concentration of circulating vascular endothelial growth factor (VEGF). The gene discussed is NECTIN2; the disease is ovarian cancer.